查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
激素避孕药市场规模、份额和趋势分析报告：按方法（宫内节育器、药丸、植入物）、按激素（组合激素避孕药、仅黄体酮）、按地区、按细分市场、预测 2022-2030 年
市场调查报告书
商品编码
1122304

激素避孕药市场规模、份额和趋势分析报告：按方法（宫内节育器、药丸、植入物）、按激素（组合激素避孕药、仅黄体酮）、按地区、按细分市场、预测 2022-2030 年

Hormonal Contraceptive Market Size, Share & Trends Analysis Report By Method (IUDs, Pills, Implants), By Hormone (Combination Hormonal Contraceptives, Progestin-only), By Region, And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

激素避孕药市场增长和趋势

根据 Grandview Research 的一份新报告，到 2030 年，全球激素避孕药市场预计将达到 242 亿美元。预计在预测期内的复合年增长率为 4.29%。在新兴地区引进创新产品和提高对生殖和性健康的认识可能是增长的驱动力。在新兴经济体，越来越多的政府举措和计划正在增加使用避孕药具的女性人数。预计这些因素将加速市场的增长。例如，根据联合国 2020 年世界生育和计划生育报告，2019 年，49% 的育龄妇女使用某种形式的避孕措施来避免怀孕，其中 91% 的人使用了植入物、补片或宫内节育器。使用最新的避孕方法，包括

根据联合国人口基金会的《2022 年世界人口状况》，全世界每年 1.21 亿次怀孕中约有 50% 是意外怀孕。为了避免不安全的堕胎，各国正在提高对避孕药具的认识，这有望推动该行业的发展。由于新设备的推出、长效可逆避孕方法的可用性以及超过 99.0% 的功效，预计 IUD 细分市场在预测期内增长最快。

由于供应链中断和计划生育人数下降，COVID-19 流行病对该行业产生了重大影响。默克公司等避孕药具製造商报告称，随着医疗保健提供者优先治疗 COVID-19 患者，对其 Nexplanon 避孕植入物的需求下降。此外，由于各种仿製药的引入，行业分散。例如，2019 年 12 月，Plasco 与默克公司合作，推出了 NuvaRing 的仿製药，一种含有乙炔雌二醇的阴道环。

激素避孕药市场报告亮点

对避孕药具的高需求是由于人们对药丸和设备的认识提高、计划生育的重要性以及政府支持政策改善了这些产品的获取。

按激素计算，由于副作用较少，出现痤疮和相关症状的可能性较小，2021 年联合激素避孕药占最大份额。

该药丸在 2021 年拥有最高的市场份额，因为它易于使用，如果服用得当，有效率超过 99.0%。

此外，易用性、副作用少和大量玩家为这一细分市场的增长做出了贡献。

北美将在 2021 年占据最大份额，由于主要市场参与者的存在、高人均收入和政府支持措施，预计在预测期内将保持其主导地位。

由于未满足的高需求、预计未来 15 年覆盖面的增加以及育龄妇女的增加，亚太地区预计将在 2022 年至 2030 年期间实现最快的复合年增长率

目录

第一章研究范围与目的

  • 市场细分
  • 区域范围
  • 研究目标

第二章研究方法论

  • 调查方法
    • 信息采购
    • 购买的数据库
    • GVR 内部数据库
    • 次要信息
    • 初步调查
  • 信息或数据分析
    • 数据分析模型
  • 市场製定和验证
  • 型号详情
    • 商品流向分析
    • 体积分析
  • 二级信息列表
  • 缩略语表

第三章执行摘要

  • 市场展望
  • 分部展望
    • 激素
    • 方法
  • 区域展望
  • 竞争考虑

第 4 章市场变量、趋势和范围

  • 市场系列展望
    • 母公司市场展望
    • 相关/子公司市场展望
  • 激素避孕药市场动态
    • 市场驱动力分析
      • 政府和非政府组织倡议推广避孕方法的兴起
      • 高未满足的需求
    • 市场约束分析
      • 人口迅速老龄化和不孕症患病率上升
      • 与使用避孕药具和避孕装置相关的不良反应
  • 激素避孕药市场：商业环境分析工具
    • 波特五力分析
    • 杵分析
      • 政治与法律
      • 经济与社会
      • 技术的
  • 绘製渗透率和增长前景
  • 定性分析：COVID-19 对激素避孕药市场的影响

5 激素避孕药市场：激素分析

  • 2021 年和 2030 年激素避孕激素市场份额分析
  • 激素避孕激素市场：细分仪表板
  • 激素细分市场规模和预测，趋势分析，2017-2030
    • 复方激素避孕药
    • 仅孕激素

6 激素避孕药市场：方法分析

  • 2021 年和 2030 年激素避孕药市场份额分析
  • 激素避孕药市场：细分仪表板
  • 方法细分市场规模和预测，趋势分析，2017-2030
    • 药丸
    • 宫内节育器（IUD）
    • 可注射的
    • 阴道环
    • 注入
    • 修补

7. 激素避孕药市场：区域分析

  • 2020 年和 2030 年激素避孕药区域市场份额分析
  • 区域市场快照
  • 2017-2030 年市场规模、预测和趋势分析
    • 北美
      • 美国
      • 加拿大
    • 欧洲
      • 英国
      • 德国
      • 法国
      • 意大利
      • 西班牙
    • 亚太地区
      • 日本
      • 中国
      • 印度
      • 澳大利亚
      • 韩国
    • 拉丁美洲
      • 墨西哥
      • 巴西
      • 阿根廷
    • 中东和非洲
      • 南非
      • 沙特阿拉伯
      • 阿拉伯联合酋长国

第 8 章 竞争分析

  • 主要市场参与者的最新发展和影响分析
  • 竞争对手分类（主要创新者、市场领导者、初创企业）
  • 公司市场分析
  • 公司简介
    • ABBVIE INC.
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • BAYER AG
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • Organon group of companies.
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • PFIZER
      • 公司简介
      • 财务绩效
      • 产品基准
    • AFAXYS, INC.
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • TEVA PHARMACEUTICAL INDUSTRIES LTD
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • AGILE THERAPEUTICS
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • JANSSEN PHARMACEUTICALS, INC.
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • Lupin Pharmaceuticals, Inc.
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • Pregna International Limited.
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
Product Code: GVR-2-68038-348-5

Hormonal Contraceptive Market Growth & Trends:

The global hormonal contraceptive market size is expected to reach USD 24.2 billion by 2030, based on a new report by Grand View Research, Inc. It is projected to register a CAGR of 4.29% during the forecast period. The introduction of innovative products and growing awareness about reproductive & sexual health in emerging regions are likely to drive the growth. An increasing number of women in developing economies are using contraceptives due to the rise in government initiatives and programs. This factor is anticipated to accelerate market growth. For instance, according to the UN World Fertility and Family Planning 2020, in 2019, 49% of the women of reproductive age received some form of contraception to avoid pregnancy with 91% of women among them using modern contraceptive methods including implants, patches, IUDs, and others.

According to the State of World Population 2022, by UNFPO, globally, approximately 50% of all 121 million pregnancies each year are unwanted. As per the Seeing, the Unseen: The case for action in the neglected crisis of unintended pregnancy, more than 60% of unwanted pregnancies result in abortion and the projected 45% among them are unsafe. Hence, to avoid unsafe abortions, countries are spreading awareness about contraceptives, which is expected to propel industry growth. The IUD segment is expected to witness the fastest growth during the forecast period due to the entry of new devices, the availability of long-acting reversible birth control methods, and more than 99.0% effectiveness.

The COVID-19 pandemic has significantly impacted the industry owing to supply chain disruptions and a decline in family planning numbers. Contraceptive manufacturers, such as Merck & Co., have reported reduced demand for the contraceptive implant, Nexplanon, due to the prioritization of COVID-19 patients by healthcare providers. The industry is fragmented owing to the introduction of various generic drugs. For instance, in December 2019, Prasco, in collaboration with Merck & Co., Inc., launched the generic version of the NuvaRing, a vaginal ring containing ethinylestradiol.

Hormonal Contraceptive Market Report Highlights:

  • High demand for contraceptive methods can be attributed to the rising awareness about pills & devices, the significance of family planning, and the presence of supportive government policies improving access to these products
  • By hormone, the combination hormonal contraceptive segment held the largest share in 2021 owing to the fewer side effects and lower chances of developing acne and related symptoms
  • Based on method, pills accounted for the largest share in 2021 as these products are convenient to use and exhibit more than 99.0% effectivity when accurately consumed
  • Furthermore, the ease of availability, fewer adverse effects, and the presence of a large number of players contribute to the segment growth
  • North America held the largest share in 2021 and is anticipated to maintain its dominance during the forecast period due to the presence of major market players, high per capita income, and supportive government initiatives
  • The Asia Pacific is estimated to witness the fastest CAGR from 2022 to 2030 due to high unmet needs, an expected increase in coverage in the next 15 years, and an increasing number of women in their reproductive age

Table of Contents

Chapter 1 Report Scope and Objectives

  • 1.1 Market Segmentation
  • 1.2 Regional Scope
  • 1.3 Estimates and Forecast Timeline
  • 1.4 Research Objectives
    • 1.4.1 Objective - 1
    • 1.4.2 Objective - 2
    • 1.4.3 Objective - 3

Chapter 2 Methodology

  • 2.1 Research Methodology
    • 2.1.1 Information procurement
    • 2.1.2 Purchased Database
    • 2.1.3 GVR's Internal Database
    • 2.1.4 Secondary Sources
    • 2.1.5 Primary Research
  • 2.2 Information or Data Analysis
    • 2.2.1 Data Analysis Models
  • 2.3 Market Formulation & Validation
  • 2.4 Model Details
    • 2.4.1 Commodity Flow Analysis
    • 2.4.2 Volume price analysis
  • 2.5 List of Secondary Sources
  • 2.6 List of Abbreviations

Chapter 3 Executive Summary

  • 3.1 Market Outlook
  • 3.2 Segment Outlook
    • 3.2.1 Hormone
    • 3.2.2 Method
  • 3.3 Regional Outlook
  • 3.4 Competitive Insights

Chapter 4 Market Variables, Trends & Scope

  • 4.1 Market Lineage Outlook
    • 4.1.1 Parent Market Outlook
    • 4.1.2 Related/Ancillary Market Outlook
  • 4.2 Hormonal Contraceptive Market Dynamics
    • 4.2.1 Market Driver Analysis
      • 4.2.1.1 Rise in government and NGO initiatives to promote contraceptive methods
      • 4.2.1.2 High unmet needs
    • 4.2.2 Market Restraint Analysis
      • 4.2.2.1 Rapidly aging population and rising prevalence of infertility
      • 4.2.2.2 Adverse effects associated with the use of contraceptive drugs and devices
  • 4.3 Hormonal Contraceptive Market: Business Environment Analysis Tools
    • 4.3.1 Porter's five forces analysis
    • 4.3.2 PESTLE Analysis
      • 4.3.2.1 Political & legal
      • 4.3.2.2 Economic & Social
      • 4.3.2.3 Technological
  • 4.4 Penetration & Growth Prospect Mapping
  • 4.5 Qualitative Analysis: Impact of COVID-19 on the Hormonal Contraceptive Market

Chapter 5 Hormonal Contraceptive Market: Hormone Analysis

  • 5.1 Hormonal Contraceptive Hormone Market Share Analysis, 2021 & 2030
  • 5.2 Hormonal Contraceptive Hormone Market: Segment Dashboard
  • 5.3 Market Size & Forecasts and Trend Analyses, 2017 - 2030 for the Hormone Segment
    • 5.3.1 Combination Hormonal Contraceptives
      • 5.3.1.1 Combination hormonal contraceptives market, 2017 - 2030 (USD Million)
    • 5.3.2 Progestin-only
      • 5.3.2.1 Progestin-only market, 2017 - 2030 (USD Million)

Chapter 6 Hormonal Contraceptive Market: Method Analysis

  • 6.1 Hormonal Contraceptive Method Market Share Analysis, 2021 & 2030
  • 6.2 Hormonal Contraceptive Method Market: Segment Dashboard
  • 6.3 Market Size & Forecasts and Trend Analyses, 2017 - 2030 for the Method Segment
    • 6.3.1 Pills
      • 6.3.1.1 Pills market, 2017 - 2030 (USD Million)
    • 6.3.2 Intrauterine Devices (IUD)
      • 6.3.2.1 Intrauterine Devices (IUD) market, 2017 - 2030 (USD Million)
    • 6.3.3 Injectable
      • 6.3.3.1 Injectable market, 2017 - 2030 (USD Million)
    • 6.3.4 Vaginal Ring
      • 6.3.4.1 Vaginal Ring market, 2017 - 2030 (USD Million)
    • 6.3.5 Implant
      • 6.3.5.1 Implant market, 2017 - 2030 (USD Million)
    • 6.3.6 Patch
      • 6.3.6.1 Patch market, 2017 - 2030 (USD Million)

Chapter 7 Hormonal Contraceptive Market: Regional Analysis

  • 7.1 Hormonal Contraceptive Regional Market Share Analysis, 2020 & 2030
  • 7.2 Regional Market Snapshot
  • 7.3 Market Size, & Forecasts and Trend Analysis, 2017 to 2030
    • 7.3.1 North America
      • 7.3.1.1 North America Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
      • 7.3.1.2 U.S.
      • 7.3.1.2.1 U.S. Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
      • 7.3.1.3 Canada
      • 7.3.1.3.1 Canada Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
    • 7.3.2 Europe
      • 7.3.2.1 Europe Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
      • 7.3.2.2 U.K.
      • 7.3.2.2.1 U.K. Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
      • 7.3.2.3 Germany
      • 7.3.2.3.1 Germany Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
      • 7.3.2.4 France
      • 7.3.2.4.1 France Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
      • 7.3.2.5 Italy
      • 7.3.2.5.1 Italy Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
      • 7.3.2.6 Spain
      • 7.3.2.5.1 Spain Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
    • 7.3.3 Asia Pacific
      • 7.3.3.1 Asia Pacific Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
      • 7.3.3.2 Japan
      • 7.3.3.2.1 Japan Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
      • 7.3.3.3 China
      • 7.3.3.3.1 China Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
      • 7.3.3.4 India
      • 7.3.3.4.1 India Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
      • 7.3.3.5 Australia
      • 7.3.3.5.1 Australia Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
      • 7.3.3.6 South Korea
      • 7.3.3.6.1 South Korea Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
    • 7.3.4 Latin America
      • 7.3.4.1 Latin America Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
      • 7.3.4.2 Mexico
      • 7.3.4.2.1 Mexico Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
      • 7.3.4.3 Brazil
      • 7.3.4.3.1 Brazil Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
      • 7.3.4.4 Argentina
      • 7.3.4.4.1 Argentina Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
    • 7.3.5 Middle East & Africa
      • 7.3.5.1 Middle East & Africa Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
      • 7.3.5.2 South Africa
      • 7.3.5.2.1 South Africa Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
      • 7.3.5.2 Saudi Arabia
      • 7.3.5.2.1 Saudi Arabia Hormonal Contraceptive Market, 2017 - 2030 (USD Million)
      • 7.3.5.3 UAE
      • 7.3.5.3.1 UAE Hormonal Contraceptive Market, 2017 - 2030 (USD Million)

Chapter 8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants
  • 8.2 Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
  • 8.3 Company Market Position Analysis
  • 8.4 Company Profiles
    • 8.4.1 ABBVIE INC.
      • 8.4.1.1 Company overview
      • 8.4.1.2 Financial performance
      • 8.4.1.3 Product benchmarking
      • 8.4.1.4 Strategic initiatives
    • 8.4.2 BAYER AG
      • 8.4.2.1 Company overview
      • 8.4.2.2 Financial performance
      • 8.4.2.3 Product benchmarking
      • 8.4.2.4 Strategic initiatives
    • 8.4.3 Organon group of companies.
      • 8.4.3.1 Company overview
      • 8.4.3.2 Financial performance
      • 8.4.3.3 Product benchmarking
      • 8.4.3.4 Strategic initiatives
    • 8.4.4 PFIZER
      • 8.4.4.1 Company overview
      • 8.4.4.2 Financial performance
      • 8.4.4.3 Product benchmarking
    • 8.4.5 AFAXYS, INC.
      • 8.4.5.1 Company overview
      • 8.4.5.2 Financial performance
      • 8.4.5.3 Product benchmarking
      • 8.4.5.4 Strategic initiatives
    • 8.4.6 TEVA PHARMACEUTICAL INDUSTRIES LTD
      • 8.4.6.1 Company overview
      • 8.4.6.2 Financial performance
      • 8.4.6.3 Product benchmarking
      • 8.4.6.4 Strategic initiatives
    • 8.4.7 AGILE THERAPEUTICS
      • 8.4.7.1 Company overview
      • 8.4.7.2 Financial performance
      • 8.4.7.3 Product benchmarking
      • 8.4.7.4 Strategic initiatives
    • 8.4.8 JANSSEN PHARMACEUTICALS, INC.
      • 8.4.8.1 Company overview
      • 8.4.8.2 Financial performance
      • 8.4.8.3 Product benchmarking
      • 8.4.8.4 Strategic initiatives
    • 8.4.9 Lupin Pharmaceuticals, Inc.
      • 8.4.9.1 Company overview
      • 8.4.9.2 Financial performance
      • 8.4.9.3 Product benchmarking
      • 8.4.9.4 Strategic initiatives
    • 8.4.10 Pregna International Limited.
      • 8.4.10.1 Company overview
      • 8.4.10.2 Financial performance
      • 8.4.10.3 Product benchmarking
      • 8.4.10.4 Strategic initiatives

List of Tables

  • TABLE 1 List of secondary sources
  • TABLE 2 List of abbreviations
  • TABLE 3 Global hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
  • TABLE 4 Global hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
  • TABLE 5 North America hormonal contraceptive market, by country, 2017 - 2030 (USD Million)
  • TABLE 6 North America hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
  • TABLE 7 North America hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
  • TABLE 8 U.S. hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
  • TABLE 9 U.S. hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
  • TABLE 10 Canada hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
  • TABLE 11 Canada hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
  • TABLE 12 Europe hormonal contraceptive market, by country, 2017 - 2030 (USD Million)
  • TABLE 13 Europe hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
  • TABLE 14 Europe hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
  • TABLE 15 Germany hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
  • TABLE 16 Germany hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
  • TABLE 17 U.K. hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
  • TABLE 18 U.K. hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
  • TABLE 19 France hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
  • TABLE 20 France hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
  • TABLE 21 Italy hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
  • TABLE 22 Italy hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
  • TABLE 23 Spain hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
  • TABLE 24 Spain hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
  • TABLE 25 Asia Pacific hormonal contraceptive market, by country, 2017 - 2030 (USD Million)
  • TABLE 26 Asia Pacific hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
  • TABLE 27 Asia Pacific hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
  • TABLE 28 Japan hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
  • TABLE 29 Japan hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
  • TABLE 30 China hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
  • TABLE 31 China hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
  • TABLE 32 India hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
  • TABLE 33 India hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
  • TABLE 34 Australia hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
  • TABLE 35 Australia hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
  • TABLE 36 South Korea hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
  • TABLE 37 South Korea hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
  • TABLE 38 Latin America hormonal contraceptive market, by country, 2017 - 2030 (USD Million)
  • TABLE 39 Latin America hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
  • TABLE 40 Latin America hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
  • TABLE 41 Brazil hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
  • TABLE 42 Brazil hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
  • TABLE 43 Mexico hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
  • TABLE 44 Mexico hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
  • TABLE 45 Argentina hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
  • TABLE 46 Argentina hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
  • TABLE 47 Middle East & Africa (MEA) hormonal contraceptive market, by country, 2017 - 2030 (USD Million)
  • TABLE 48 Middle East & Africa (MEA) hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
  • TABLE 49 Middle East & Africa (MEA) hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
  • TABLE 50 South Africa hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
  • TABLE 51 South Africa hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
  • TABLE 52 Saudi Arabia hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
  • TABLE 53 Saudi Arabia hormonal contraceptive market, by method, 2017 - 2030 (USD Million)
  • TABLE 54 UAE hormonal contraceptive market, by hormone, 2017 - 2030 (USD Million)
  • TABLE 55 UAE hormonal contraceptive market, by method, 2017 - 2030 (USD Million)

List of Figures

  • FIG. 1 Hormonal contraceptives market segmentation
  • FIG. 2 Market research process
  • FIG. 3 Information procurement
  • FIG. 4 Primary research pattern
  • FIG. 5 Market research approaches
  • FIG. 6 Value chain-based sizing & forecasting
  • FIG. 7 QFD modeling for market share assessment
  • FIG. 8 Market formulation & validation
  • FIG. 9 Hormonal contraceptive market outlook, 2021
  • FIG. 10 Hormonal contraceptive market trends & outlook
  • FIG. 11 Market driver relevance analysis (Current & future impact)
  • FIG. 12 Market restraint relevance analysis (Current & future impact)
  • FIG. 13 Penetration & growth prospect mapping
  • FIG. 14 Hormonal contraceptives market: Hormone movement analysis (USD Million)
  • FIG. 15 Hormonal contraceptives market hormone outlook: Key takeaways (USD Million)
  • FIG. 16 Combination hormonal contraceptives market, 2017 - 2030 (USD Million)
  • FIG. 17 Progestin-only market, 2017 - 2030 (USD Million)
  • FIG. 19 Pill market, 2017 - 2030 (USD Million)
  • FIG. 20 Hormonal contraceptives market: Method movement analysis (USD Million)
  • FIG. 21 Hormonal contraceptives market method outlook: Key takeaways (USD Million)
  • FIG. 22 Intrauterine device market, 2017 - 2030 (USD Million)
  • FIG. 23 Injectable market, 2017 - 2030 (USD Million)
  • FIG. 24 Vaginal ring market, 2017 - 2030 (USD Million)
  • FIG. 25 Implant market, 2017 - 2030 (USD Million)
  • FIG. 26 Patch market, 2017 - 2030 (USD Million)
  • FIG. 27 Regional outlook, 2021 & 2030
  • FIG. 28 Regional marketplace: Key takeaways
  • FIG. 29 North America hormonal contraceptive market, 2017 - 2030 (USD Million)
  • FIG. 30 U.S. hormonal contraceptive market, 2017 - 2030 (USD Million)
  • FIG. 31 Canada hormonal contraceptive market, 2017 - 2030 (USD Million)
  • FIG. 32 Europe hormonal contraceptive market, 2017 - 2030 (USD Million)
  • FIG. 33 U.K. hormonal contraceptive market, 2017 - 2030 (USD Million)
  • FIG. 34 Germany hormonal contraceptive market, 2017 - 2030 (USD Million)
  • FIG. 35 France hormonal contraceptive market, 2017 - 2030 (USD Million)
  • FIG. 36 Italy hormonal contraceptive market, 2017 - 2030 (USD Million)
  • FIG. 37 Spain hormonal contraceptive market, 2017 - 2030 (USD Million)
  • FIG. 38 Asia Pacific hormonal contraceptive market, 2017 - 2030 (USD Million)
  • FIG. 39 Japan hormonal contraceptive market, 2017 - 2030 (USD Million)
  • FIG. 40 China hormonal contraceptive market, 2017 - 2030 (USD Million)
  • FIG. 41 Australia hormonal contraceptive market, 2017 - 2030 (USD Million)
  • FIG. 42 South Korea hormonal contraceptive market, 2017 - 2030 (USD Million)
  • FIG. 43 Latin America hormonal contraceptive market, 2017 - 2030 (USD Million)
  • FIG. 44 Brazil hormonal contraceptive market, 2017 - 2030 (USD Million)
  • FIG. 45 Mexico hormonal contraceptive market, 2017 - 2030 (USD Million)
  • FIG. 46 Argentina hormonal contraceptive market, 2017 - 2030 (USD Million)
  • FIG. 47 MEA hormonal contraceptive market, 2017 - 2030 (USD Million)
  • FIG. 48 South Africa hormonal contraceptive market, 2017 - 2030 (USD Million)
  • FIG. 49 Saudi Arabia hormonal contraceptive market, 2017 - 2030 (USD Million)
  • FIG. 50 UAE hormonal contraceptive market, 2017 - 2030 (USD Million)
  • FIG. 51 Recent developments and impact analysis
  • FIG. 52 Company categorization
  • FIG. 53 Company market position analysis